Works matching AU He, Weizhong


Results: 40
    1
    2
    3

    Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study.

    Published in:
    Rheumatology & Therapy, 2019, v. 6, n. 4, p. 503, doi. 10.1007/s40744-019-00167-6
    By:
    • Genovese, Mark C.;
    • Greenwald, Maria W.;
    • Gutierrez-Ureña, Sergio R.;
    • Cardiel, Mario H.;
    • Poiley, Jeffrey E.;
    • Zubrzycka-Sienkiewicz, Anna;
    • Codding, Christine E.;
    • Wang, Annie;
    • He, Weizhong;
    • Amos, Rebecca;
    • Vinueza, Raul;
    • Wang, Xuegong;
    • Garg, Jay P.;
    • Kivitz, Alan J.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40